5737 related articles for article (PubMed ID: 23610971)
1. Carboplatin and sodium butyrate, separate--yes, but combined--never.
Gurtowska N; Kloskowski T; Olkowska J; Bajek A; Debski R; Zielaskowska J; Drewa T
Acta Pol Pharm; 2013; 70(1):153-61. PubMed ID: 23610971
[TBL] [Abstract][Full Text] [Related]
2. Ovarian tumor initiating cell populations persist following paclitaxel and carboplatin chemotherapy treatment in vivo.
Kulkarni-Datar K; Orsulic S; Foster R; Rueda BR
Cancer Lett; 2013 Oct; 339(2):237-46. PubMed ID: 23791886
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
[TBL] [Abstract][Full Text] [Related]
4. Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells.
Yang Q; Zhang T; Wang C; Jiao J; Li J; Deng Y
Eur J Pharm Biopharm; 2014 Nov; 88(3):737-45. PubMed ID: 25460146
[TBL] [Abstract][Full Text] [Related]
5. Sodium butyrate enhances the cytotoxic effect of cisplatin by abrogating the cisplatin imposed cell cycle arrest.
Koprinarova M; Markovska P; Iliev I; Anachkova B; Russev G
BMC Mol Biol; 2010 Jun; 11():49. PubMed ID: 20576112
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells.
Cunneen TS; Conway RM; Madigan MC
Arch Ophthalmol; 2009 Apr; 127(4):414-20. PubMed ID: 19365017
[TBL] [Abstract][Full Text] [Related]
7. Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection.
Sgambato A; Puglisi MA; Errico F; Rafanelli F; Boninsegna A; Rettino A; Genovese G; Coco C; Gasbarrini A; Cittadini A
J Cell Physiol; 2010 Jul; 224(1):234-41. PubMed ID: 20333645
[TBL] [Abstract][Full Text] [Related]
8. CD133+CD44+ population efficiently enriches colon cancer initiating cells.
Haraguchi N; Ohkuma M; Sakashita H; Matsuzaki S; Tanaka F; Mimori K; Kamohara Y; Inoue H; Mori M
Ann Surg Oncol; 2008 Oct; 15(10):2927-33. PubMed ID: 18663533
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of tributyrin emulsion as a potent anti-cancer agent against melanoma.
Kang SN; Lee E; Lee MK; Lim SJ
Drug Deliv; 2011 Feb; 18(2):143-9. PubMed ID: 20946006
[TBL] [Abstract][Full Text] [Related]
10. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma.
Dos Santos MP; de Farias CB; Roesler R; Brunetto AL; Abujamra AL
Oncol Rep; 2014 Feb; 31(2):955-68. PubMed ID: 24316794
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line.
Chen W; Wei F; Xu J; Wang Y; Chen L; Wang J; Guan X
Int J Mol Med; 2011 Dec; 28(6):985-91. PubMed ID: 21887460
[TBL] [Abstract][Full Text] [Related]
12. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
[TBL] [Abstract][Full Text] [Related]
13. Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells.
Shin H; Lee YS; Lee YC
Oncol Rep; 2012 Apr; 27(4):1111-5. PubMed ID: 22160140
[TBL] [Abstract][Full Text] [Related]
14. Influence of sodium butyrate on hepatocellular carcinoma (hepG2) and glioblastoma (C6) cell lines in vitro.
Joachimiak R; Kaźnica A; Drewa T
Acta Pol Pharm; 2007; 64(6):561-3. PubMed ID: 18323252
[TBL] [Abstract][Full Text] [Related]
15. Acetylcarnitine potentiates the anticarcinogenic effects of butyrate on SW480 colon cancer cells.
Elimrani I; Dionne S; Saragosti D; Qureshi I; Levy E; Delvin E; Seidman EG
Int J Oncol; 2015 Aug; 47(2):755-63. PubMed ID: 26043725
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle analysis of the CD133(+) and CD133(-) cells isolated from human colorectal cancer.
Gharagozloo M; Mirzaei HR; Bagherpour B; Rezaei A; Kalantari H; Sanei MH; Hosseini M; Mohajeri G; Tabatabai A; Hashemi M
J Cancer Res Ther; 2012; 8(3):399-403. PubMed ID: 23174722
[TBL] [Abstract][Full Text] [Related]
17. Expression of multidrug resistance genes in normal and cancer stem cells.
Shervington A; Lu C
Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
[TBL] [Abstract][Full Text] [Related]
18. Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines.
Foglietta F; Serpe L; Canaparo R; Vivenza N; Riccio G; Imbalzano E; Gasco P; Zara GP
J Pharm Pharm Sci; 2014; 17(2):231-47. PubMed ID: 24934552
[TBL] [Abstract][Full Text] [Related]
19. Effects of tachyplesin and n-sodium butyrate on proliferation and gene expression of human gastric adenocarcinoma cell line BGC-823.
Shi SL; Wang YY; Liang Y; Li QF
World J Gastroenterol; 2006 Mar; 12(11):1694-8. PubMed ID: 16586536
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma.
Yu D; Liu Y; Yang J; Jin C; Zhao X; Cheng J; Liu X; Qi X
Cell Biochem Biophys; 2015 Jan; 71(1):261-9. PubMed ID: 25241082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
